Yiling Pharmaceutical

Yiling Pharmaceutical, established in 1992, is a prominent publicly traded pharmaceutical manufacturer headquartered in China. Specializing in both traditional Chinese medicine (TCM) and chemical pharmaceutical products, the company adheres to stringent quality control measures. Yiling operates GMP-authorized TCM production lines and EU-authorized chemical agent production workshops, underscoring its commitment to high manufacturing standards. Recognized as a national innovation enterprise, Yiling Pharmaceutical has solidified its position among the top 50 pharmaceutical companies within China, demonstrating significant contributions to the healthcare sector.

With an employee base exceeding 10,000 individuals and generating approximately $1.2B in revenue, Yiling Pharmaceutical manages operations across multiple locations throughout the Asia-Pacific region, serving both domestic and international markets. The company's extensive product portfolio includes critical medical and health solutions, such as cardiovascular medications, antipyretics, and diabetes management products. This broad range of offerings reflects Yiling's comprehensive approach to public health. To understand the driving force behind these operations, you can Meet Yiling Pharmaceutical's team and learn about their leadership and expertise.

Yiling Pharmaceutical's strategic focus on innovation, coupled with its dual expertise in TCM and modern pharmaceuticals, positions it as a key player in the global healthcare landscape. The company's dedication to research and development fuels its ability to produce advanced medical treatments and health products. Its consistent ranking among China's leading pharmaceutical firms highlights its sustained growth and market influence. Yiling continues to expand its reach, offering vital pharmaceutical solutions to a diverse patient population worldwide.